Indeed, the mutant p53 protein inhibits the Sestrin 1 (SESN1)/AMPK/PPARγ coactivator 1 (PGC1) pathway, which is a transcriptional axis that activates UCP2, and consequently the inhibition of this signaling pathway stimulates O2− production in cancer cell lines. This evidence concerns the gene TP53 and cancer.